BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 10807457)

  • 21. [C-reactive protein as an independent marker of prognosis in acute coronary syndrome: comparison with troponin T].
    Möckel M; Heller G; Müller C; Klefisch FR; Riehle M; Searle J; Frei U; Störk T
    Z Kardiol; 2000 Aug; 89(8):658-66. PubMed ID: 11013970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Independent role of C reactive protein to predict major events at one-month and at one-year in acute coronary syndrome without ST elevation].
    Bodí V; Sanchis J; Llàcer A; Fácila L; Núñez J; Pellicer M; Bertomeu V; Ruiz V; García D; Chorro FJ
    Med Clin (Barc); 2004 Feb; 122(7):248-52. PubMed ID: 15012872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Redefining medical treatment in the management of unstable angina.
    Braunwald E; Califf RM; Cannon CP; Fox KA; Fuster V; Gibler WB; Harrington RA; King SB; Kleiman NS; Theroux P; Topol EJ; Van de Werf F; White HD; Willerson JT
    Am J Med; 2000 Jan; 108(1):41-53. PubMed ID: 11059440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical utility of troponin T levels and echocardiography in the emergency department.
    Mohler ER; Ryan T; Segar DS; Sawada SG; Sonel AF; Perkins L; Fineberg N; Feigenbaum H; Wilensky RL
    Am Heart J; 1998 Feb; 135(2 Pt 1):253-60. PubMed ID: 9489973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute rest perfusion imaging in high risk unstable angina: association with troponin T and clinical endpoints.
    Dinckal MH; Aksoy N; Aksoy M; Davutoglu V; Dinckal N; Soydinc S; Akdemir I
    Int J Cardiovasc Imaging; 2003 Dec; 19(6):511-7. PubMed ID: 14690190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular risk and therapeutic benefit of coronary interventions for patients with unstable angina according to the troponin T status.
    Heeschen C; Goldmann BU; Terres W; Hamm CW
    Eur Heart J; 2000 Jul; 21(14):1159-66. PubMed ID: 10924299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy.
    James SK; Armstrong P; Barnathan E; Califf R; Lindahl B; Siegbahn A; Simoons ML; Topol EJ; Venge P; Wallentin L;
    J Am Coll Cardiol; 2003 Mar; 41(6):916-24. PubMed ID: 12651034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
    Adgey AA
    Eur Heart J; 1998 Apr; 19 Suppl D():D10-21. PubMed ID: 9597518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential benefits and outcomes of tirofiban vs abciximab for acute coronary syndromes in current clinical practice.
    Gowda MS; Vacek JL; Lakkireddy DJ; Brosnahan K; Beauchamp GD
    Angiology; 2003; 54(2):211-8. PubMed ID: 12678197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic and differential diagnostic value of troponins].
    Prellwitz W; Hafner G; Rupprecht HJ; Meyer J
    Med Klin (Munich); 1996 Jun; 91(6):336-42. PubMed ID: 8767305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma levels of B-type natriuretic Peptide in patients with unstable angina pectoris or acute myocardial infarction: prognostic significance and therapeutic implications.
    Ahmed W; Zafar S; Alam AY; Ahktar N; Shah MA; Alpert MA
    Angiology; 2007; 58(3):269-74. PubMed ID: 17626979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-reactive protein and the stress tests for the risk stratification of patients recovering from unstable angina pectoris.
    Bazzino O; Ferreirós ER; Pizarro R; Corrado G
    Am J Cardiol; 2001 Jun; 87(11):1235-9. PubMed ID: 11377346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty.
    Wöhrle J; Grebe OC; Nusser T; Al-Khayer E; Schaible S; Kochs M; Hombach V; Höher M
    Circulation; 2003 Apr; 107(14):1840-3. PubMed ID: 12682003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary angiographic findings and troponin T in patients with unstable angina pectoris.
    Jurlander B; Farhi ER; Banas JJ; Keany CM; Balu D; Grande P; Ellis AK
    Am J Cardiol; 2000 Apr; 85(7):810-4. PubMed ID: 10758918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiac troponin I and T in unstable angina: incidence, correlation, kinetics of release and prognostic value].
    Musso P; Vernocchi A; Pasquino M; Crippa A; Ottello B; Panteghini M; Pinnavaia A; Ronzani G; Bajardi D; Aquaro G
    G Ital Cardiol; 1996 Sep; 26(9):1013-23. PubMed ID: 9036039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Does abciximab improve the prognosis of diabetics after percutaneous coronary intervention?].
    Hernández García JM; Domínguez Franco A; Jiménez-Navarro MF; Alonso Briales JH; Curiel Balsera E; Gómez Doblas JJ; De Teresa Galván E
    Rev Esp Cardiol; 2002 Aug; 55(8):810-5. PubMed ID: 12199976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication.
    Topol EJ; Ferguson JJ; Weisman HF; Tcheng JE; Ellis SG; Kleiman NS; Ivanhoe RJ; Wang AL; Miller DP; Anderson KM; Califf RM
    JAMA; 1997 Aug; 278(6):479-84. PubMed ID: 9256222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnostic and prognostic value of atherosclerosis risk factors for predicting 1 year outcome in patients with acute myocardial infarction and in patients with stable coronary artery disease receiving percutaneous transluminal coronary angioplasty].
    Drobniak-Hełdak D; Kolasińska-Kloch W; Rajtar-Salwa R
    Folia Med Cracov; 2009; 50(3-4):43-54. PubMed ID: 21853870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function.
    Palazzuoli A; Deckers J; Calabrò A; Campagna MS; Nuti R; Pastorelli M; Pasqui AL; Bruni F; Auteri A; Puccetti L
    Am J Cardiol; 2006 Nov; 98(10):1322-8. PubMed ID: 17134622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment.
    Iijima R; Ndrepepa G; Mehilli J; Neumann FJ; Schulz S; ten Berg J; Bruskina O; Dotzer F; Dirschinger J; Berger PB; Schömig A; Kastrati A
    Clin Res Cardiol; 2008 Mar; 97(3):160-8. PubMed ID: 18046527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.